View all Courses
Biopharmaceutical Science
Bachelor of Science (Honours)
Course Details
Course Code | SG_SBIOP_K08 |
---|---|
Level | 8 |
Duration | 2 years |
Credits | 60 |
Method of Delivery | Online |
Campus Locations | Sligo |
Mode of Delivery | Part Time |
Course Overview
This programme in Biopharmaceutical Science aims to provide students with a comprehensive understanding of the critical aspects of Biopharmaceutical Processing and Support Services, with specific focus on the product lifecycle of Biological products and associated processes. One of the key features of the programme is that it combines cutting-edge skills in Biopharmaceutical Science and Medical Biotechnology with an understanding of the legislative and quality control system framework in which this takes place within the industry.
This programme is jointly offered by ATU Sligo and NIBRT (National Institute for Bioprocessing Research and Training).
Biopharmaceutical Science involves study of the discovery, development and processing of modern, medical drugs by artificially growing some or all of the components utilising cell culture technologies. The processes involved are more biological-based as compared to the more chemical-based processes associated with small-molecule pharmaceutical products. The Medical Biotechnology and Biopharmaceutical sectors are among the fastest growing in the Life Sciences area both nationally and internationally.
Please note: This programme is jointly offered by ATU Sligo and NIBRT (National Institute for Bioprocessing Research and Training).
Course Details
Year 1
Semester | Module Details | Credits | Mandatory / Elective |
---|---|---|---|
1 |
Lean SigmaThis module examines all aspects of the application of Lean Processing and Six Sigma principles and tools as they apply to the modern manufacturing environment. Learning Outcomes 1. Evaluate and discuss the key principles of Lean Manufacturing and their typical applications for manufacturing. |
05 | Mandatory |
1 |
Cell Culture ProcessingThis module aims to provide learners with a deep understanding of the theory of mammalian cell culture processing as it pertains to the biosynthesis of modern biopharmaceutical products. It will examine the processing flow from cell vial thaw and subsequent scale-up through to protein synthesis and product formation. Consideration will be given to the development and characterisation of cell lines for use in biomanufacturing, the kinetics of cell growth and media requirements to optimise cell performance and productivity. The learner will be exposed to a detailed comparative discussion of mammalian cell bioreactor design, operation, and control for the successful manufacture of biotherapeutic proteins. Learning Outcomes 1. Describe the fundamentals of mammalian cell biology and cell line development and explain the process kinetics relating to cell growth and productivity for a bioreactor process. 2. Identify the key components of mammalian cell culture media formulations and relate those to the optimisation of a cell culture process. 3. Compare and contrast the most common bioreactor designs available, their key features and the relative advantages and disadvantages in different operating modes. 4. Describe the key steps in bioreactor operation, the critical control parameters and the main operating and control loops associated with bioreactor performance monitoring. 5. Analyse, evaluate and draw conclusions from data obtained from lab. demonstrations and/or data obtained from problem solving exercises. 6. Perform research on a relevant topic and communicate in writing and orally an informed and evidence based analysis and evaluation of current thinking, with appropriate conclusions. |
05 | Mandatory |
1 |
Quality Systems and Regulatory AffairsThis module addresses ICH legislation for biopharmaceutical processing. It also introduces GMP, environmental and health and safety legislation relevant to the biopharmaceutical industry. Learning Outcomes 1. Demonstrate abroad-based knowledge and understanding of the main US and EU institutions, legal instruments, ICH process and workings of EMEA. |
05 | Mandatory |
2 |
Protein PurificationThis module aims to provide the learner with a deep understanding of the key theoretical concepts and principles of protein purification (downstream processing) as part of biotherapeutic protein manufacturing. The module will address all key steps in downstream processing from product recovery using different filtration techniques and/or centrifugation, to protein product capture, purification and polishing using various chromatographic techniques, and viral clearance. Consideration will be given to the selection of chromatographic methods, their operation, process scale-up and evaluation of column performance. Sources of viral loads from cell culture and other avenues will be discussed including techniques for their elimination. Learning Outcomes 1. Outline the main elements of an effective and efficient downstream process design for protein capture and purification. 3. Discuss the general theory and principles of chromatography technology for protein purification applications and the application of this theory to evaluating column performance. 4. Compare and contrast the different types and modes of chromatography used in downstream processing. 5. Describe the various viral exclusion and elimination technologies for downstream processing as well as relevant quality control methods. 6. Perform research on a relevant topic and communicate in writing and orally an informed and evidence based analysis and evaluation of current thinking, with appropriate conclusions. |
05 | Mandatory |
2 |
Biopharmaceutical ValidationThis course aims to provide the student with a broad understanding of the various aspects of process and support systems validation for the manufacturing of modern biopharmaceuticals. It will deal with the various risks inherent in bioprocessing technologies and how the application of effective validation methodologies assists in the control and management of such risks. Learning Outcomes 1. Describe the key elements in a systematic approach to validation with particular emphasis on their application to bioprocessing. 3. Evaluate the main steps involved in the process validation of the biopharmaceutical manufacture upstream process (cell culture processing). 4. Evaluatethe main steps involved in the process validation of the biopharmaceutical manufacture downstream process (protein purification). 5. Describe the validation approach for viral control technologies for biopharmaceutical manufacture. |
05 | Mandatory |
2 |
BioanalyticsThis module aims to provide students with a detailed knowledge and understanding of the various analytical assays routinely employed in the analysis of critical quality attributes (CQAs) of biopharmaceuticals. These analytical assays are used to assess the raw material, in-process, bulk drug substance and finished product quality attributes. Learning Outcomes 1. Outline and evaluate the various assays/tests methods and instrumentation routinely employed in the analysis of Biopharmaceuticals. |
05 | Mandatory |
3 |
Biocontamination ControlThis module aims to provide students with a detailed knowledge and understanding of the general principles and methods of Biocontamination control; establishing and verifying the formal system for contamination control and associated test methods and requirements; traditional and modern methods of microbial detection; expressing, interpreting and reporting results; training and documentation requirements. Learning Outcomes 1. Discuss and critically evaluate the most relevant microbes for the biopharmaceutical industry and identify and discuss appropriate prevention techniques for each contaminant. 2. Source and interpret the theory behind the detection test methods available, including traditional and rapid identification testing. 3. Develop and justify an appropriate monitoring regime for a pharmaceutical/biopharmaceutical facility. |
05 | Mandatory |
3 |
Formulation Fill Finish and Delivery of BiopharmaceuticalsThis module aims to provide students with an understanding of the main considerations in the formulation and fill finish of a biopharmaceutical. Learning Outcomes 1. Describe protein structure and what contributes to protein destabilisation. 2. Describe what excipients are added to a protein formulation and why they are added. 3. Explain the principles and applications of typical fill-finish and freeze-drying technologies. 4. Perform research on a relevant topic and analyse, evaluate and draw conclusions accordingly. |
05 | Mandatory |
3 |
Recombinant Drug Development and EngineeringThe subject aim is to introduce the students to the drug discovery and development process. The subject will compare traditional pharmaceutical drug development to biopharmaceutical drug development. The module will include an in depth study of the different modes and methods of recombinant protein expression in different cellular hosts. The module will introduce the analysis and manipulation of recombinant protein expression in the biopharmaceutical sector. Learning Outcomes 1. Differentiate between irrational and rational drug design. Describe the methods of drug target identification and validation. 3. Categorize the essential steps in the design and regulation of a recombinant expression system. |
05 | Mandatory |
4 |
Biopharmaceutical Facilities and UtilitiesThis module aims to provide the student with a good understanding of the main support service areas involving both facilities and utilities that underpin the modern biopharmaceutical manufacturing industry. Learning Outcomes 1. Outline the main elements and features of facilities and utilities relating to the modern biopharmaceutical industry. 6. Perform research on a relevant topic and analyse, evaluate and draw conclusions accordingly.Communicate and explain scientific data relating to facilities and utilities for biopharmaceutical processing. |
05 | Mandatory |
4 |
Biopharmaceutical Science ProjectThe project aims to provide students with the opportunity to apply and integrate the skills and knowledge they have gained on the programme of study to date. The student should bring the learning from the modules covered in the course to conceive, define and agree a project which is relevant to the subject matter they are studying. A supervisor will be assigned to each project. The supervisor will act as a guide in agreeing the relevance and scope of the project and monitor the progress on a regular basis. Updates will be sent to the supervisor on an agreed basis. Learning Outcomes 1. Identify a problem which needs to be addressed of importance to the organisation. |
10 | Elective |
4 |
Biopharmaceutical Science PracticalThis Biopharma laboratory practical module will provide students with practical knowledge, know-how and practical skills associated with biopharmaceutical operations. The relevant learning is achieved through the completion of a sequence of laboratory-based and pilot-plant based practicals and experiments that are designed to impart the required expertise. There will also be some research project work associated with the laboratory practicals. Learning Outcomes 1. Demonstrate a range of practical knowledge and skills associated with upstream bioprocessing operations 2. Demonstrate a range of practical knowledge and skills associated downstream bioprocessing operations. 3. Demonstrate a range of practical knowledge and skills associated with aseptic processing and filling operations 4. Perform project work related to the practical sessions 5. Evaluate the data and results obtained from the practical sessions 6. Demonstrate effective communication skills in a written format. |
10 | Elective |
Recommended Study Hours per week
Examination and Assessment
On-Campus Attendance Requirement
Progression
Student who successfully graduate from this programme may apply to various postgraduate programmes available in ATU.
Download a prospectus
Entry Requirements
Candidates will be expected to hold a cognate Level 7 degree, typically in Science or Engineering, with a second class honours grade or higher. Applicants with other qualifications and with relevant work experience may also be considered through ATU Sligos RPL (Recognised Prior Learning) process.
Applicants who may not have the aforementioned qualifications but who may have relevant industrial experience may apply for consideration under the RPL (Recognised Prior Learning) process in accordance with the policies of ATU Sligo in this area.
RPL is a process that may allow you to gain admission to a programme or to receive exemptions / credit from some parts of a programme based on demonstrated learning that you may have achieved through another programme of study or through your work and career. Further information is available through www.atu.ie/recognition-of-prior-learning which our dedicated RPL portal or by contacting our admissions team at admissions.sligo@atu.ie
English requirement
Applicants whose first language is not English should provide evidence of English language proficiency. For further information on English language requirements click here
Careers
Graduates from this programme can expect to find employment in the Biopharmaceutical, Biotechnology, Medical Diagnostics, Medical Devices and Pharmaceutical sectors, as well as more broadly in the area of analytical science. In the development of this programme emphasis has been placed on aligning the course content with the skills required by the Biopharmaceutical industry, whilst ensuring that there is sufficient flexibility to allow students to move laterally into associated careers including Research and Development opportunities.
Graduates are typically employed in Scientific, Operations and Quality Assurance / Control positions in the Biopharmaceutical and Biotechnology industry sectors both in Ireland and abroad. Their work may involve the manufacture of novel medicines from living cells, immunodiagnostics, bioanalytics, process validation and process optimisation
Further Information
Who Should Apply?
Graduates from this programme can expect to find employment in the Biopharmaceutical, Biotechnology, Medical Diagnostics, Medical Devices and Pharmaceutical sectors, as well as more broadly in the area of analytical science.
Contact Information
Life Sciences